Literature DB >> 11457653

Levels of dopamine in blood and brain following nasal administration to rats.

M Dahlin1, B Jansson, E Björk.   

Abstract

The aim of this study was to investigate the levels of [(3)H]dopamine in blood, the cerebrospinal fluid (CSF) and brain tissue samples in rats and to find out whether the drug is transferred along the olfactory pathway to the central nervous system following nasal administration. [(3)H]Dopamine (50 microCi) was given to male Sprague-Dawley rats either intravenously or nasally to the right nostril. For the absorption study, blood samples were withdrawn from the carotid artery. The CSF samples were taken by cisternal puncture and then brain tissue samples were excised. The presence of unchanged dopamine in the samples was ascertained using thin layer chromatography (TLC). The radioactivity in the samples was measured using liquid scintillation. The greatest amount of the total radioactivity absorbed from the nasal mucosa into the systemic circulation was observed at the first sampling point 15 min after administration. The bioavailability of the total radioactivity was 68+/-30%. The uptake of [(3)H]dopamine in the brain was significantly higher 30 min after nasal administration than after intravenous administration (P<0.01). TLC data showed that approximately 59%, 14% and 68% of the radioactivity in the olfactory bulb, CSF and olfactory mucosa, respectively, coeluted with dopamine. In conclusion, these results show that unchanged dopamine is transferred into the olfactory bulb via the olfactory pathway in rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11457653     DOI: 10.1016/s0928-0987(01)00151-8

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  14 in total

1.  Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures.

Authors:  Neil J Johnson; Leah R Hanson; William H Frey
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

2.  Acute intranasal dopamine application counteracts the reversal learning deficit of spontaneously hypertensive rats in an attentional set-shifting task.

Authors:  Jay-Shake Li; Shan-Sung Yang; Joseph P Huston; Owen Y Chao; Yi-Mei Yang; Claudia Mattern
Journal:  Psychopharmacology (Berl)       Date:  2021-05-12       Impact factor: 4.530

3.  Effects of localized hydrophilic mannitol and hydrophobic nelfinavir administration targeted to olfactory epithelium on brain distribution.

Authors:  John Douglas Hoekman; Rodney J Y Ho
Journal:  AAPS PharmSciTech       Date:  2011-04-26       Impact factor: 3.246

4.  Correlation between nasal membrane permeability and nasal absorption rate.

Authors:  Hefei Zhang; Chih-Wei Lin; Maureen D Donovan
Journal:  AAPS PharmSciTech       Date:  2012-12-07       Impact factor: 3.246

5.  Permeability of dopamine D2 receptor agonist hordenine across the intestinal and blood-brain barrier in vitro.

Authors:  Maria Hahn; Viktoria Lindemann; Matthias Behrens; Dennis Mulac; Klaus Langer; Melanie Esselen; Hans-Ulrich Humpf
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

6.  Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study.

Authors:  Mascha P van den Berg; Paul Merkus; Stefan G Romeijn; J Coos Verhoef; Frans W H M Merkus
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

7.  Brain Targeting of Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor K-604 via the Intranasal Route Using a Hydroxycarboxylic Acid Solution.

Authors:  Kimiyuki Shibuya; Shigeru Morikawa; Masayoshi Miyamoto; Shin-Ichiro Ogawa; Yoshihiko Tsunenari; Yasuomi Urano; Noriko Noguchi
Journal:  ACS Omega       Date:  2019-10-02

8.  A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs.

Authors:  Jasper Stevens; Ernst Suidgeest; Piet Hein van der Graaf; Meindert Danhof; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2009-05-19       Impact factor: 4.200

9.  Intranasal Dopamine Reduces In Vivo [(123)I]FP-CIT Binding to Striatal Dopamine Transporter: Correlation with Behavioral Changes and Evidence for Pavlovian Conditioned Dopamine Response.

Authors:  Maria A de Souza Silva; Claudia Mattern; Cvetana Decheva; Joseph P Huston; Adolfo G Sadile; Markus Beu; H-W Müller; Susanne Nikolaus
Journal:  Front Behav Neurosci       Date:  2016-04-22       Impact factor: 3.558

Review 10.  Progress in drug delivery to the central nervous system by the prodrug approach.

Authors:  Barbara Pavan; Alessandro Dalpiaz; Nunzia Ciliberti; Carla Biondi; Stefano Manfredini; Silvia Vertuani
Journal:  Molecules       Date:  2008-05-01       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.